Watch Ticker

uniQure N.V.

Go to uniQure N.V. Website

$14.00

0.23 (1.67%)

Live

Previous Close

$13.77

Day Range

$13.42 - $14.23

Previous Day Range

$13.36 - $14.065

Market Cap

$751.4 million USD

Day Vol.

1.2 million

Previous Day Vol.

709651

Currency

USD

Primary Exchange

Nasdaq

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - uniQure Announces Appointment of Kylie O’Keefe as Chief Customer and Strategy Officer

uniQure, a gene therapy company, has appointed Kylie O'Keefe as Chief Customer and Strategy Officer to lead the commercialization of its investigational gene therapy AMT-130 for the treatment of Huntington's disease.

Related tickers: QURE.

Read Full Article

Prnewswire - CSL Behring's Gene Therapy HEMGENIX® (etranacogene dezaparvovec-drlb) Four Years Post-Infusion Data Continue to Show Sustained Efficacy and Safety in Adults with Hemophilia B

CSL Behring's gene therapy HEMGENIX has shown sustained efficacy and safety in treating adults with hemophilia B, with 94% of patients remaining free of continuous prophylaxis treatment four years after a single infusion.

Related tickers: CSLLY, QURE.

Read Full Article

Trending Tickers

Please sign in to view